Replies to post #355568 on Amarin Corp Plc (AMRN)

[Invest83838]

MoMoney, Can You Back Up That Claim?

That is very interesting if true

[JBWIN]

Besides BMY's 11.5% ownership of XLRN, BMY has 75-80% of Reblozyl economics, 20% royalty of XLRN's eventual potential multi-blockbuster Sotatercept in PAH,

The potential size of PAH could atrract multiple large biopharma.

[ggwpq]

Glad it's not Pfizer,

Merck Said to Agree to $180-Per-Share Cash Deal to Buy Acceleron:

https://news.bloomberglaw.com/pharma-and-life-sciences/merck-said-to-agree-to-180-per-share-cash-deal-to-buy-acceleron